Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

94 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Switching to biological DMARDs versus cycling among JAK inhibitors in patients with rheumatoid arthritis and with inadequate response to JAK inhibitors: from FIRST registry.
Miyazaki Y, Nakayamada S, Tanaka H, Hanami K, Fukuyo S, Kubo S, Yamaguchi A, Miyagawa I, Satoh-Kanda Y, Todoroki Y, Inoue Y, Ueno M, Tanaka Y. Miyazaki Y, et al. Among authors: todoroki y. RMD Open. 2025 Jan 21;11(1):e004987. doi: 10.1136/rmdopen-2024-004987. RMD Open. 2025. PMID: 39842873
Induction of interleukin 21 receptor expression via enhanced intracellular metabolism in B cells and its relevance to the disease activity in systemic lupus erythematosus.
Ueno M, Iwata S, Yamagata K, Todoroki Y, Sonomoto K, Nagayasu A, Miyagawa I, Kubo S, Miyazaki Y, Miyata H, Kanda R, Aritomi T, Nakayamada S, Tanaka Y. Ueno M, et al. Among authors: todoroki y. RMD Open. 2024 Dec 31;10(4):e004567. doi: 10.1136/rmdopen-2024-004567. RMD Open. 2024. PMID: 39740932 Free PMC article.
MS-DIAL 5 multimodal mass spectrometry data mining unveils lipidome complexities.
Takeda H, Matsuzawa Y, Takeuchi M, Takahashi M, Nishida K, Harayama T, Todoroki Y, Shimizu K, Sakamoto N, Oka T, Maekawa M, Chung MH, Kurizaki Y, Kiuchi S, Tokiyoshi K, Buyantogtokh B, Kurata M, Kvasnička A, Takeda U, Uchino H, Hasegawa M, Miyamoto J, Tanabe K, Takeda S, Mori T, Kumakubo R, Tanaka T, Yoshino T, Okamoto M, Takahashi H, Arita M, Tsugawa H. Takeda H, et al. Among authors: todoroki y. Nat Commun. 2024 Nov 28;15(1):9903. doi: 10.1038/s41467-024-54137-w. Nat Commun. 2024. PMID: 39609386 Free PMC article.
Peripheral blood immunophenotypic diversity in patients with rheumatoid arthritis and its impact on therapeutic responsiveness.
Kubo S, Miyazaki Y, Nishino T, Fujita Y, Kono M, Kawashima T, Ishigaki K, Kusaka K, Tanaka H, Ueno M, Satoh-Kanda Y, Inoue Y, Todoroki Y, Miyagawa I, Hanami K, Nakayamada S, Tanaka Y. Kubo S, et al. Among authors: todoroki y. Ann Rheum Dis. 2024 Oct 4:ard-2024-226228. doi: 10.1136/ard-2024-226228. Online ahead of print. Ann Rheum Dis. 2024. PMID: 39366723
Efficacy, safety, and optimal intervention of belimumab for proliferative lupus nephritis patients in real-world settings: LOOPS registry.
Sakai H, Miyazaki Y, Nakayamada S, Kubo S, Hanami K, Fukuyo S, Yamaguchi A, Miyagawa I, Ueno M, Tanaka H, Todoroki Y, Ohkubo N, Funada M, Matsunaga S, Tanaka Y. Sakai H, et al. Among authors: todoroki y. Rheumatology (Oxford). 2024 Sep 17:keae495. doi: 10.1093/rheumatology/keae495. Online ahead of print. Rheumatology (Oxford). 2024. PMID: 39288317
Efficacy and Safety of Biologics in Polymyalgia Rheumatica: A Retrospective Study.
Ohkubo N, Miyazaki Y, Nakayamada S, Fukuyo S, Inoue Y, Satoh-Kanda Y, Tanaka H, Todoroki Y, Miyata H, Nagayasu A, Funada M, Kobayashi H, Sakai H, Kosaka S, Matsunaga S, Tomoyose Y, Nohara H, Tanaka Y. Ohkubo N, et al. Among authors: todoroki y. Rheumatol Ther. 2024 Oct;11(5):1303-1319. doi: 10.1007/s40744-024-00707-9. Epub 2024 Aug 9. Rheumatol Ther. 2024. PMID: 39120846 Free PMC article.
94 results